Indications for therapy for fungemia in postoperative patients.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMID 7125890)

Published in Arch Surg on October 01, 1982

Authors

J S Solomkin, A M Flohr, R L Simmons

Articles by these authors

Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. J Immunol (1975) 8.06

Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer (1979) 5.60

Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science (1992) 3.80

Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J Exp Med (1992) 3.42

Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine (Baltimore) (1980) 3.42

Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci U S A (1993) 3.24

Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy. Ann Surg (1983) 3.15

Use of medical emergency team responses to reduce hospital cardiopulmonary arrests. Qual Saf Health Care (2004) 3.00

A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med (1989) 2.78

Surgically induced leukocytic infiltrates within the rat intestinal muscularis mediate postoperative ileus. Gastroenterology (1999) 2.75

Effect of prophylactic administration of recombinant human granulocyte colony-stimulating factor (filgrastim) on the frequency of nosocomial infections in patients with acute traumatic brain injury or cerebral hemorrhage. The Filgrastim Study Group. Crit Care Med (1998) 2.74

Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells. J Exp Med (1989) 2.49

Immunodepression after major surgery in normal patients. Surgery (1975) 2.48

Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci U S A (1993) 2.46

Pancreatico-duodenal allotransplantation: experimental and clinical experience. Ann Surg (1970) 2.44

Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med (1982) 2.44

The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation (1987) 2.40

Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation (1985) 2.34

An L-arginine-dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro. J Exp Med (1989) 2.27

Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res (1981) 2.25

Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg (1991) 2.24

Proposed mechanisms for the translocation of intestinal bacteria. Rev Infect Dis (1988) 2.16

Modulation of nitrogen oxide synthesis in vivo: NG-monomethyl-L-arginine inhibits endotoxin-induced nitrate/nitrate biosynthesis while promoting hepatic damage. J Leukoc Biol (1990) 2.11

Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol (1991) 2.07

Chemiluminescence response of phagocytizing human monocytes. Infect Immun (1976) 2.01

Surgical manipulation of the gut elicits an intestinal muscularis inflammatory response resulting in postsurgical ileus. Ann Surg (1998) 2.00

Association of renal allograft rejection with virus infections. Am J Med (1974) 1.83

Pancreatic trauma: a review. Surgery (1972) 1.81

Antiserum to lymphocytes: prolonged survival of canine renal allografts. Science (1966) 1.81

Increased incidence of malignancy during chronic renal failure. Lancet (1975) 1.79

Family tension in the search for a kidney donor. JAMA (1971) 1.77

Chemiluminescence response of human leukocytes: influence of medium components on light production. Infect Immun (1977) 1.77

Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine. J Immunol (1990) 1.76

Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis. Ann Surg (1990) 1.74

Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. Proc Natl Acad Sci U S A (1996) 1.71

Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet (1972) 1.71

Reactive nitrogen intermediates suppress the primary immunologic response to Listeria. J Immunol (1993) 1.69

Role of inducible nitric oxide synthase in postoperative intestinal smooth muscle dysfunction in rodents. Gastroenterology (2000) 1.69

Inducible cytosolic enzyme activity for the production of nitrogen oxides from L-arginine in hepatocytes. Biochem Biophys Res Commun (1990) 1.67

Complement activation and lung permeability during cardiopulmonary bypass. Ann Thorac Surg (1990) 1.65

Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats. Science (1976) 1.65

Antimicrobial prophylaxis for surgical wounds. Guidelines for clinical care. Arch Surg (1993) 1.64

Comparison of FK-506 and cyclosporine regimens in pediatric renal transplantation. Pediatr Nephrol (1994) 1.55

Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am J Physiol (1991) 1.54

Inhibition of chemotaxis Ng-monomethyl-L-arginine: a role for cyclic GMP. Blood (1989) 1.53

Hemorrhagic shock. Curr Probl Surg (1995) 1.53

The Epstein-Barr virus in the pathogenesis of posttransplant lymphoproliferative disorders. Clinical, pathologic, and virologic correlation. Surgery (1981) 1.53

Induction of nitric oxide synthase in mouse dendritic cells by IFN-gamma, endotoxin, and interaction with allogeneic T cells: nitric oxide production is associated with dendritic cell apoptosis. J Immunol (1996) 1.53

Mechanisms of microbial synergy in polymicrobial surgical infections. Rev Infect Dis (1985) 1.51

Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood (1994) 1.49

Nitric oxide and nitric oxide-generating compounds inhibit hepatocyte protein synthesis. FASEB J (1991) 1.48

Role of anaerobic flora in the translocation of aerobic and facultatively anaerobic intestinal bacteria. Infect Immun (1987) 1.46

Evidence that rat Kupffer cells stimulate and inhibit hepatocyte protein synthesis in vitro by different mechanisms. Gastroenterology (1989) 1.45

Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery (1977) 1.45

Coagulation disorders in combat casualties. I. Acute changes after wounding. II. Effects of massive transfusion. 3. Post-resuscitative changes. Ann Surg (1969) 1.44

Use of medical emergency team (MET) responses to detect medical errors. Qual Saf Health Care (2004) 1.43

Steroid diabetes in renal transplant recipients: pathogenetic factors and prognosis. Surgery (1973) 1.43

Suppression of lipopolysaccharide-induced macrophage nitric oxide and cytokine production in vitro by a novel lipopolysaccharide antagonist. Surgery (1994) 1.42

Intra-abdominal infections in pancreas transplant recipients. Ann Surg (1986) 1.42

Thigh abscess. An uncommon presentation of intraabdominal sepsis. Am J Surg (1986) 1.41

Anatomic evidence for spontaneous closure of ventricular septal defect. Circulation (1966) 1.41

Hyperglycemic nonketotic coma after liver transplantation. Arch Surg (1972) 1.40

Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells. J Leukoc Biol (1993) 1.40

Uremic pericardial effusion. Treatment by catheter drainage and local nonabsorbable steroid administration. Nephron (1976) 1.39

Anti-serum to cultured human lymphoblasts: preparation, purification and immunosuppressive properties in man. Ann Surg (1969) 1.37

Isolation of Chlamydia trachomatis from the lower respiratory tract of adults. Lancet (1980) 1.37

Cyclosporin A in renal transplantation: a prospective randomized trial. Surgery (1982) 1.36

Cure of dysgerminoma with widespread metastases appearing after renal transplantation. N Engl J Med (1970) 1.36

Role of resident macrophages, peripheral neutrophils, and translymphatic absorption in bacterial clearance from the peritoneal cavity. Infect Immun (1985) 1.35

Guidelines for clinical care: anti-infective agents for intra-abdominal infection. A Surgical Infection Society policy statement. Arch Surg (1992) 1.34

Cytomegalovirus: Clinical virological correlations in renal transplant recipients. Ann Surg (1974) 1.34

Herpes simplex virus hepatitis after solid organ transplantation in adults. J Infect Dis (1991) 1.33

A central role for IL-1 beta in the in vitro and in vivo regulation of hepatic inducible nitric oxide synthase. IL-1 beta induces hepatic nitric oxide synthesis. J Immunol (1995) 1.33

Pathologic anatomy of the lungs following shock and trauma. J Trauma (1968) 1.33

Chemotactic deactivation of human neutrophils: evidence for nonspecific and specific components. Infect Immun (1978) 1.33

Immunotherapy of cancer: immunospecific rejection of tumors in recipients of neuraminidase-treated tumor cells plus BCG. Science (1971) 1.33

Effect of neuraminidase on the stimulatory capacity of cells in human mixed lymphocyte cultures. Clin Exp Immunol (1971) 1.32

Acquired immunologic deficiencies after trauma and surgical procedures. Surg Gynecol Obstet (1974) 1.30

Immunogenicity and antigenicity of lymphoid cells treated with neuraminidase. Nat New Biol (1971) 1.29

Prevention of urological complications after kidney transplantation. Ann Surg (1971) 1.29

Renal transplantation in high-risk patients. Arch Surg (1971) 1.28

Secondary bacterial peritonitis: the biologic basis of treatment. Curr Probl Surg (1979) 1.28

Chemotactic deactivation of human neutrophils: possible relationship to stimulation of oxidative metabolism. Infect Immun (1979) 1.27

Proposed definitions for diagnosis, severity scoring, stratification, and outcome for trials on intraabdominal infection. Joint Working Party of SIS North America and Europe. World J Surg (1990) 1.26

Seven years' experience with antilymphoblast globulin for renal transplantation from cadaver donors. Ann Surg (1976) 1.26

Antibiotic trials in intra-abdominal infections. A critical evaluation of study design and outcome reporting. Ann Surg (1984) 1.26

Renal transplantation in children ages 1 to 5 years. Pediatrics (1978) 1.25

Cellular non-heme iron content is a determinant of nitric oxide-mediated apoptosis, necrosis, and caspase inhibition. J Biol Chem (2000) 1.25

Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical-mediated hepatic injury. J Leukoc Biol (1992) 1.25

Intestinal bacteria translocate into experimental intra-abdominal abscesses. Arch Surg (1986) 1.24

Fibrin in peritonitis. I. Beneficial and adverse effects of fibrin in experimental E. coli peritonitis. Surgery (1980) 1.24

The clinical use of antilymphocyte globulin. N Engl J Med (1971) 1.24

Incidence of trimethoprim-sulfamethoxazole-resistant enterobacteriaceae among transplant recipients. J Infect Dis (1984) 1.24

EPR detection of heme and nonheme iron-containing protein nitrosylation by nitric oxide during rejection of rat heart allograft. J Biol Chem (1992) 1.24

Biphasic response to gut manipulation and temporal correlation of cellular infiltrates and muscle dysfunction in rat. Surgery (1999) 1.24

Role of virus infections in immunosuppressed renal transplant patients. Transplant Proc (1973) 1.23

The role of Candida in intraperitoneal infections. Surgery (1980) 1.22

Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate. J Vasc Surg (2000) 1.22